Jpmorgan Chase & CO Haleon PLC Transaction History
Jpmorgan Chase & CO
- $1.14 Trillion
- Q2 2024
A detailed history of Jpmorgan Chase & CO transactions in Haleon PLC stock. As of the latest transaction made, Jpmorgan Chase & CO holds 4,057,263 shares of HLN stock, worth $39.5 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,057,263
Previous 3,153,086
28.68%
Holding current value
$39.5 Million
Previous $26.8 Million
25.19%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding HLN
# of Institutions
620Shares Held
422MCall Options Held
165KPut Options Held
26.7K-
Dodge & Cox San Francisco, CA180MShares$1.75 Billion0.94% of portfolio
-
Clearbridge Investments, LLC New York, NY41.8MShares$406 Million0.29% of portfolio
-
Harding Loevner LP Bridgewater, NJ25.6MShares$249 Million1.2% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa14MShares$136 Million0.05% of portfolio
-
Aristotle Capital Management, LLC Los Angeles, CA9.05MShares$88.1 Million0.15% of portfolio
About Haleon plc
- Ticker HLN
- Exchange
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 4,617,290,240
- Market Cap $44.9B
- Description
- Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, mineral...